Why the study?
Despite well-established evidence for LDL-C lowering, many patients with acute myocardial infarction have untreated or undertreated lipid levels before and after the event, reflecting gaps in risk identification and treatment intensification.
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Milani et al. (2026) conducted an editorial in Acute Myocardial Infarction (n=1,848). Lipid-lowering therapy prescribing was evaluated on Statin usage at presentation and combination lipid-lowering therapy at discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: